Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 51, 2021 - Issue 8
832
Views
7
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Employing in vitro metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds

, , , , , & show all
Pages 885-900 | Received 03 May 2021, Accepted 11 Jun 2021, Published online: 30 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Gabriel Bernardes & Ed S. Krol. (2023) In vitro hepatic metabolism of the natural product quebecol. Xenobiotica 53:1, pages 1-11.
Read now
Omozojie P. Aigbogun, Chukwunonso K. Nwabufo, Madeline N. Owens, Kevin J. H. Allen, Jeremy S. Lee, Christopher P. Phenix & Ed S. Krol. (2022) An HPLC-UV validated bioanalytical method for measurement of in vitro phase 1 kinetics of α-synuclein binding bifunctional compounds. Xenobiotica 52:8, pages 916-927.
Read now
Aarzoo Thakur, Zhiyuan Tan, Tsubasa Kameyama, Eman El-Khateeb, Shakti Nagpal, Stephanie Malone, Rohitash Jamwal & Chukwunonso K. Nwabufo. (2021) Bioanalytical strategies in drug discovery and development. Drug Metabolism Reviews 53:3, pages 434-458.
Read now

Articles from other publishers (4)

Gabriel Bernardes, Omer Munir & Ed S. Krol. (2023) The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro. Bioorganic & Medicinal Chemistry 78, pages 117147.
Crossref
Chukwunonso K. Nwabufo & Reina Bendayan. (2022) Pharmacokinetic considerations to optimize clinical outcomes for COVID-19 drugs. Trends in Pharmacological Sciences 43:12, pages 1041-1054.
Crossref
Chukwunonso K. Nwabufo & Omozojie P. Aigbogun. (2022) Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson’s disease. Journal of Neurology 269:11, pages 5762-5786.
Crossref
Chukwunonso K. Nwabufo. (2022) Relevance of ABC Transporters in Drug Development. Current Drug Metabolism 23:6, pages 434-446.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.